The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells
2018 ◽
Keyword(s):
2015 ◽
Vol 137
(3)
◽
pp. 698-709
◽
Keyword(s):
2007 ◽
Vol 213
(1)
◽
pp. 212-220
◽
2009 ◽
Vol 33
(11)
◽
pp. 1520-1524
◽
Keyword(s):
Keyword(s):